NeuroOne Medical Technolo... (NMTC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.02
-0.03 (-2.86%)
At close: Jan 21, 2025, 3:59 PM
1.06
4.06%
After-hours Jan 21, 2025, 06:51 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
Net Income | -12.32M | -11.86M | -10.00M | -9.95M | -13.64M | -6.78M | -6.76M | -5.06M | -47.77K | -62.86K | -36.24K | -30.55K | -13.96K | -27.60K | -6.04K |
Depreciation & Amortization | 246.79K | 199.27K | 118.62K | 80.75K | 47.61K | 27.57K | 20.56K | 17.63K | 7.74K | 7.76K | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.34M | 1.11M | 947.21K | 1.79M | 1.84M | 491.75K | 486.12K | 76.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | -1.19M | 1.29M | -15.80K | -159.96K | -872.49K | 1.77K | 859.89K | -453 | 17.98K | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | -285.00K | 96.40K | 212.16K | 69.44K | 6.74M | 284.56K | 3.42M | 2.00M | 15.62K | 16.76K | 330.00 | 4.00K | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | -11.47K | -85.31K | 2.02M | 683.21K | n/a | 590.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -2.43M | 1.21M | -512.73K | -429.56K | -101.88K | 1.77K | 859.89K | 11.05K | 15.87K | 9.74K | 1.46K | 227.00 | 176.00 | 952.00 |
Operating Cash Flow | -11.01M | -12.89M | -7.52M | -8.60M | -3.43M | -5.40M | -2.83M | -2.11M | -21.11K | -30.23K | -26.17K | -25.09K | -13.73K | -27.43K | -5.09K |
Capital Expenditures | -120.20K | -384.12K | -275.23K | -67.08K | -122.43K | -123.35K | n/a | -91.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Acquisitions | n/a | n/a | 2.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -1.47M | -3.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 4.50M | 500.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 7.50K | -2.97M | n/a | n/a | -65.00K | -146.71K | -91.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -120.20K | 2.65M | -3.24M | -67.08K | -122.43K | -123.35K | -146.71K | -91.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | 8.44M | -283.00K | n/a | 954.13K | n/a | n/a | 3.23K | 11.00K | 1K | 3.50K | 12.50K |
Common Stock Repurchased | n/a | -119.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.48M | -1.07M | -1.33M | 2.71M | -1.51M | 1.49M | 2.92M | 749.90K | 21.11K | 30.02K | 22.63K | 13.50K | n/a | n/a | n/a |
Financial Cash Flow | 7.27M | 7.40M | 12.02M | 11.53M | 7.32M | 5.77M | 2.92M | 1.70M | 21.11K | 30.02K | 25.85K | 24.50K | 1K | 32.15K | 13.00K |
Net Cash Flow | -3.86M | -2.84M | 1.26M | 2.86M | 3.78M | 247.49K | -56.77K | -495.75K | n/a | -205 | -320 | -593 | -12.73K | 4.72K | 7.91K |
Free Cash Flow | -11.13M | -13.27M | -7.79M | -8.67M | -3.55M | -5.52M | -2.83M | -2.20M | -21.11K | -30.23K | -26.17K | -25.09K | -13.73K | -27.43K | -5.09K |